- Home
- CYBN vs FINW Comparison
CYBN vs FINW Comparison
Compare CYBN & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBN
- FINW
- Stock Information
- Founded
- CYBN 2019
- FINW 1999
- Country
- CYBN Canada
- FINW United States
- Employees
- CYBN N/A
- FINW N/A
- Industry
- CYBN Pharmaceuticals and Biotechnology
- FINW Commercial Banks
- Sector
- CYBN Health Care
- FINW Finance
- Exchange
- CYBN Nasdaq
- FINW Nasdaq
- Market Cap
- CYBN 176.0M
- FINW 207.1M
- IPO Year
- CYBN N/A
- FINW 2021
- Fundamental
- Price
- CYBN $7.11
- FINW $19.30
- Analyst Decision
- CYBN Strong Buy
- FINW Buy
- Analyst Count
- CYBN 3
- FINW 4
- Target Price
- CYBN $85.00
- FINW $20.75
- AVG Volume (30 Days)
- CYBN 351.0K
- FINW 17.8K
- Earning Date
- CYBN 08-13-2025
- FINW 10-23-2025
- Dividend Yield
- CYBN N/A
- FINW N/A
- EPS Growth
- CYBN N/A
- FINW N/A
- EPS
- CYBN N/A
- FINW 0.96
- Revenue
- CYBN N/A
- FINW $74,999,000.00
- Revenue This Year
- CYBN N/A
- FINW $52.89
- Revenue Next Year
- CYBN N/A
- FINW $20.66
- P/E Ratio
- CYBN N/A
- FINW $20.09
- Revenue Growth
- CYBN N/A
- FINW 10.21
- 52 Week Low
- CYBN $4.81
- FINW $12.22
- 52 Week High
- CYBN $13.88
- FINW $20.94
- Technical
- Relative Strength Index (RSI)
- CYBN 45.43
- FINW 69.53
- Support Level
- CYBN $6.36
- FINW $18.20
- Resistance Level
- CYBN $7.75
- FINW $19.10
- Average True Range (ATR)
- CYBN 0.34
- FINW 0.65
- MACD
- CYBN -0.04
- FINW -0.05
- Stochastic Oscillator
- CYBN 51.95
- FINW 83.73
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.